Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study

A Mussetti*, B Rius-Sansalvador, V Moreno, C Peczynski, E Polge, J E Galimard, N Kröger, D Blaise, R Peffault de Latour, A Kulagin, A Mousavi, M Stelljes, R M Hamladji, J M Middeke, U Salmenniemi, H Sengeloev, E Forcade, U Platzbecker, P Reményi, E AngelucciP Chevallier, I Yakoub-Agha, C Craddock, F Ciceri, T Schroeder, M Aljurf, Koenecke Ch, I Moiseev, O Penack, H Schoemans, M Mohty, B Glass, A Sureda, G Basak, Z Peric

*Corresponding author for this work

Fingerprint

Dive into the research topics of 'Artificial intelligence methods to estimate overall mortality and non-relapse mortality following allogeneic HCT in the modern era: an EBMT-TCWP study'. Together they form a unique fingerprint.

Medicine & Life Sciences